OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study
Lakshmi Rajdev, Chia-Ching J. Wang, Himanshu Joshi, et al.
Cancer (2023) Vol. 130, Iss. 6, pp. 985-994
Closed Access | Times Cited: 8
Lakshmi Rajdev, Chia-Ching J. Wang, Himanshu Joshi, et al.
Cancer (2023) Vol. 130, Iss. 6, pp. 985-994
Closed Access | Times Cited: 8
Showing 8 citing articles:
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma
Kathryn Lurain, Ramya Ramaswami, Irene Ekwede, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 4
Kathryn Lurain, Ramya Ramaswami, Irene Ekwede, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 4
Mapping the potential for anti-PD-1 therapy in advanced rare skin carcinomas
Clio Dessinioti, Alexander J. Stratigos
European Journal of Cancer (2025), pp. 115403-115403
Closed Access
Clio Dessinioti, Alexander J. Stratigos
European Journal of Cancer (2025), pp. 115403-115403
Closed Access
Utilizing immunotherapy towards achieving a functional cure for HIV-1
Fabrícia Heloisa Cavicchioli Sugiyama, Lisa Loksø Dietz, Ole S. Søgaard
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 187-193
Closed Access | Times Cited: 3
Fabrícia Heloisa Cavicchioli Sugiyama, Lisa Loksø Dietz, Ole S. Søgaard
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 187-193
Closed Access | Times Cited: 3
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
Eléonora De Martin, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.
Gut (2024), pp. gutjnl-332125
Closed Access | Times Cited: 3
Eléonora De Martin, Claudia Angela Maria Fulgenzi, Ciro Celsa, et al.
Gut (2024), pp. gutjnl-332125
Closed Access | Times Cited: 3
Durable radiologic and molecular complete response following nivolumab in an HNSCC patient with UV signature and HIV
Ashkan Adibi, Ünal Metin Tokat, Eylül Özgü, et al.
Oral Oncology (2024) Vol. 154, pp. 106859-106859
Closed Access | Times Cited: 1
Ashkan Adibi, Ünal Metin Tokat, Eylül Özgü, et al.
Oral Oncology (2024) Vol. 154, pp. 106859-106859
Closed Access | Times Cited: 1
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study
Lambert Assoumou, Raghiatou Baldé, Christine Katlama, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e009728-e009728
Open Access | Times Cited: 1
Lambert Assoumou, Raghiatou Baldé, Christine Katlama, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 8, pp. e009728-e009728
Open Access | Times Cited: 1
Immune checkpoint inhibitors in infectious disease
Hannah A. D. King, Sharon R. Lewin
Immunological Reviews (2024)
Open Access | Times Cited: 1
Hannah A. D. King, Sharon R. Lewin
Immunological Reviews (2024)
Open Access | Times Cited: 1
Current Advances and Challenges in the Management of Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients
Sophie H. Li, Thomas Townes, Shorook Na’ara
Cancers (2024) Vol. 16, Iss. 18, pp. 3118-3118
Open Access | Times Cited: 1
Sophie H. Li, Thomas Townes, Shorook Na’ara
Cancers (2024) Vol. 16, Iss. 18, pp. 3118-3118
Open Access | Times Cited: 1
